UDG Healthcare Public Limited Co. Notice of Preliminary Results (1483V)
November 01 2017 - 3:00AM
UK Regulatory
TIDMUDG
RNS Number : 1483V
UDG Healthcare Public Limited Co.
01 November 2017
1 November 2017
UDG Healthcare plc
Notice of Preliminary Results
UDG Healthcare plc ("the Group"), a leading international
healthcare services provider, will issue its full year results for
the year ending 30 September 2017 at 07:00am (GMT) on Tuesday 28
November 2017.
Brendan McAtamney, CEO and Alan Ralph, CFO will be hosting a
presentation for analysts and investors at the London Stock
Exchange at 08:30am (GMT) to discuss the company's full year
results and provide an update on each of the Group's divisions.
They will be joined for a Q&A session by other members of the
management team including Jez Moulding, Chief Operating Officer of
UDG Healthcare and Executive Vice-President of Ashfield and Mike
O'Hara, Managing Director of Sharp Packaging Services.
Analysts and investors wishing to attend are asked to contact
Powerscourt on the details below, as all attendees need to be
pre-registered. The presentation will also be available via live
audio webcast and conference call, the details of which are
below.
Audio webcast:
https://edge.media-server.com/m6/p/ypnmwqt7
Conference call dial-in details:
UK +44(0)20-3427-1916
-------------------------- -------------------
Ireland +353(0)-1-246-5603
-------------------------- -------------------
United States of America +1-646-254-3366
-------------------------- -------------------
Participant Code 9761269
-------------------------- -------------------
For further information, please contact:
UDG Healthcare plc
Keith Byrne
Head of Investor Relations, Strategy
& Corporate Communications
Tel: +353-1-468-9000
Powerscourt
Lisa Kavanagh / Isabelle Saber
Tel: +44-207-250-1446
udghealthcare@powerscourt-group.com
About UDG Healthcare plc:
UDG Healthcare plc (LON: UDG) is a leading international partner
of choice delivering commercial, clinical, communications and
packaging services to the healthcare industry, employing over 9,000
people with operations in 24 countries and delivering services in
over 50 countries.
UDG Healthcare plc operates across three divisions: Ashfield,
Sharp and Aquilant.
Ashfield is a global leader in commercialisation services for
the pharmaceutical and healthcare industry, operating across two
broad areas of activity: commercial & clinical services, and
communications services. It focuses on supporting healthcare
professionals and patients at all stages of the product life cycle.
The division provides field and contact centre sales teams,
healthcare communications, patient support, audit, advisory,
medical information and event management services to over 300
healthcare companies.
Sharp is a global leader in contract commercial packaging and
clinical trial packaging services for the pharmaceutical and
biotechnology industries, operating from state of the art
facilities across the US and Europe.
Aquilant is a leading provider of outsourced sales, marketing,
distribution and engineering services to the medical and scientific
sectors in the UK, Ireland and the Netherlands.
The company is listed on the London Stock Exchange and is a
constituent of the FTSE 250.
For more information, please go to: www.udghealthcare.com
This information is provided by RNS
The company news service from the London Stock Exchange
END
NORZMMFGKMNGNZM
(END) Dow Jones Newswires
November 01, 2017 03:00 ET (07:00 GMT)
Udg Healthcare Public (LSE:UDG)
Historical Stock Chart
From Mar 2024 to Apr 2024
Udg Healthcare Public (LSE:UDG)
Historical Stock Chart
From Apr 2023 to Apr 2024